Skip to main content
Eli Ipp, MD, Endocrinology, Torrance, CA

EliIppMD

Endocrinology • Torrance, CA

Diabetes, Lipid Metabolism

Professor of Medicine, UCLA

Join to view full profile

Dr. Ipp is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ipp's full profile

Already have an account?

  • Office

    21840 Normandie Ave
    Ste 700
    Torrance, CA 90502
    Phone+1 310-222-5101
    Fax+1 310-320-5463

Education & Training

  • University of the Witwatersrand
    University of the WitwatersrandClass of 1968

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1985 - 2026
  • IL State Medical License
    IL State Medical License 1980 - 1987
  • TX State Medical License
    TX State Medical License 1977 - 1985
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Press Mentions

  • Researchers Study Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic Retinopathy
    Researchers Study Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic RetinopathyJune 5th, 2019
  • Robocalls Improve Diabetes Eye Screening Among Low-Income Minorities
    Robocalls Improve Diabetes Eye Screening Among Low-Income MinoritiesMarch 17th, 2018

Grant Support

  • Genetics Of Diabetic Retinopathy In HispanicsNational Center For Research Resources2008–2010
  • Beta Cell Compensatory Factors In Insulin ResistanceNational Center For Research Resources2008–2010
  • Transplantation Alone (ITA) In Patients With Difficult Control Type I DiabeteNational Center For Research Resources2005–2010
  • Insulinopenic Type 2 Diabetes In HispanicsNational Center For Research Resources2005–2010
  • Evaluation And Mechanisms In Insulin Secreting TumorsNational Center For Research Resources2004–2010
  • Acquisition Center For Gennid ProjectNational Center For Research Resources2004–2010
  • Mexican American Admixture Mapping Development And Application To NIDDM (Non-National Center For Research Resources2006–2009
  • Islet Cell Transplantation Alone (ITA)National Center For Research Resources2008
  • Clinical Trial: Insulin Resistance In The Islets Of LangerhansNational Center For Research Resources2008
  • Insulin Resistance In The Islets Of LangerhansNational Center For Research Resources2004–2007
  • Randomized, Multicenter, Double-Blind, Placebo Controlled Study With Two Para...National Center For Research Resources2004
  • Microvascular Disease Of The Heart In Type 2 Diabetes MellitusNational Center For Research Resources2004
  • HNF-1 A Polymorphism In Mexican Americans: Effect On Insulin SecretionNational Center For Research Resources2004
  • Diabetes Prevention Protocol--Type 1National Center For Research Resources1997–2001
  • Case Management In NIDDMNational Center For Research Resources1997–2001
  • Insulin Secreting Tumors--Improved Diagnostic ApproachesNational Center For Research Resources1995–2001
  • Central Control Of Glucose Homeostasis--Studies Of Glucose ThresholdNational Center For Research Resources1993–2001
  • Androgen Ablation And Comorbid Disease In Prostate CancerNational Center For Research Resources2000
  • Physiological Characterization Of NIDDMNational Center For Research Resources1993–2000
  • Medical Student Doctoring Module--Lifestyle Changes/Clinical Research ExposureNational Center For Research Resources1998–1999
  • Hyperglycemia In Glucagon Stimulated C Peptide In Type II DMNational Center For Research Resources1998–1999
  • Integration Of Hormonal Signals In HypoglycemiaNational Center For Research Resources1997
  • Follow UP Of Gestational Diabetes Mellitus In HispanicsNational Center For Research Resources1996–1997
  • Physiological Characteristics Of Response To Glipizide In NIDDMNational Center For Research Resources1992–1997
  • Insulin Infusion Test As A Diagnositic Tool In HypoglycemiaNational Center For Research Resources1996
  • Exercise To Hepatic Integration Of Hormonal Signals In HypoglycemiaNational Center For Research Resources1996
  • Exercise Intervention To Prevent NIDDM In Hispanic WomenNational Center For Research Resources1996
  • Effect Of Hyperglycemia Upon Glucagon Stimulated C Peptide In DMNational Center For Research Resources1996
  • Diabetes Prevention Protocol-Type 1National Center For Research Resources1996
  • Physiological Characterization Of NIDDMNational Center For Research Resources1990–1996
  • Physiological Characteristics Of Response To Glipizide In NIDDMNational Center For Research Resources1988–1996
  • Follow UP Of Gestational Diabetes Mellitus In Hispanic WomenNational Center For Research Resources1995
  • Insulin Infusion Test As A Diagnostic Tool In Investigation Of HypoglycemiaNational Center For Research Resources1994
  • Hyperglycemia In Glucagon Stimulated C-Peptide Secretion In Type II DMNational Center For Research Resources1994
  • Follow-Up Of Gestational Diabetes Mellitus In Hispanic WomenNational Center For Research Resources1994
  • Type II Diabetes MellitusNational Center For Research Resources1992–1994
  • Insulin-Secreting Tumors--Improved Diagnostic ApproachesNational Center For Research Resources1992–1994
  • Follow-Up Gestational Diabetes Mellitus In Hispanic WomenNational Center For Research Resources1993
  • Insulin Infusion Test As Diagnostic Tool In Investigation Of HypoglycemiaNational Center For Research Resources1992–1993
  • Glucagon Stimulated C-Peptide Secretion--Effect Of HyperglycemiaNational Center For Research Resources1992–1993
  • Follow-Up Of Gestational Diabetes Mellitus In HispanicsNational Institute Of Diabetes And Digestive And Kidney Diseases1992
  • Central Control Of Glucose HomeostasisNational Center For Research Resources1992
  • Type II Diabetes MellitusNational Center For Research Resources1990–1991
  • Insulin-Secreting Tumors--Improved Diagnostic ApproachesNational Center For Research Resources1989–1991
  • Glucagon-Stimulated C-Peptide Secretion--Effect Of HyperglycemiaNational Center For Research Resources1989–1991
  • Central Control Of Glucose HomeostasisNational Center For Research Resources1987–1991
  • Insulin Infusion Test As Diagnostic Tool In Investigation Of HypoglycemiaNational Center For Research Resources1985–1991
  • SMS 201-995 In Treating Functional Islet Cell TumorsNational Center For Research Resources1989
  • Glucagon-Stimulated C-Peptide Secretion Effect Of Hyperglycemia/DiabetesNational Center For Research Resources1987–1988

Dr. Eli Ipp, Dr. Eli Ipp, MD, Dr. E Ipp